Sasol Ltd. (SAOA.SG)
| Previous close | 11.70 |
| Open | 11.80 |
| Bid | 11.35 x 50000 |
| Ask | 12.55 x 100000 |
| Day's range | 11.40 - 11.80 |
| 52-week range | 11.20 - 26.20 |
| Volume | |
| Avg. volume | 67 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 21 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Sasol launches venture capital fund to advance decarbonisation ambitions
JOHANNESBURG, February 21, 2023--Sasol has announced that it has established Sasol Ventures to advance Sasol’s decarbonisation and 2050 net zero ambitions through venture capital. It will invest €50 million over the next five years, making it the largest chemicals and industry venture capital fund in South Africa.
- Business Wire
Sasol Chemicals supports INERATEC’s new synthetic fuel plant with free catalyst for their innovative FT-reactors
HAMBURG, Germany, February 13, 2023--Sasol Chemicals will deliver a first fill of its latest Fischer-Tropsch (FT) catalyst free of charge to Ineratec, in one of several recent commitments to promising renewable projects. The FT catalyst will be used in the lighthouse project the Karlsruhe-based clean tech company is currently building at Industriepark Hoechst near Frankfurt, Germany.
- Business Wire
Holiferm and Sasol Chemicals Expand Collaboration to Develop and Market Sustainable Surfactants
HAMBURG, Germany, January 25, 2023--Holiferm Limited and Sasol Chemicals, a business unit of Sasol Ltd. (JSE: SOL; NYSE: SSL), announced today a collaboration to produce and market rhamnolipids and mannosylerythritol lipids (MELs). This collaboration expands the partnership announced in March 2022 between the two companies to develop and commercialise another biosurfactant product, sophorolipids.
